Indivior's Monthly Injectable Buprenorphine Wins Panel Backing; US FDA May Limit Dosage

 
• By Brenda Sandburg
vialandmultiplesyringes_1200x675

More from US FDA Performance Tracker

More from Regulatory Trackers